OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025

Rhea-AI Summary

OPKO Health (NASDAQ: OPK) has announced it will release its fourth quarter and full-year 2024 financial results on February 27, 2025, after U.S. market close. The company will host a conference call and live audio webcast at 4:30 p.m. Eastern time on the same day, where senior management will provide a business update, discuss results, and share financial guidance.

Participants can pre-register for the conference call through a provided link to receive immediate access. Those unable to pre-register can dial 833-630-0584 (U.S.) or 412-317-1815 (International). A telephone replay will be available until March 6, 2025, and a webcast replay will be accessible approximately one hour after the live call.

MIAMI, Feb. 13, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2024 after the close of the U.S. financial markets on Thursday, February 27, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on February 27^th beginning at 4:30 p.m. Eastern time.

CONFERENCE CALL & WEBCAST INFORMATION

OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed at OPKO’s Investor Relations page and here.

A telephone replay will be available until March 6, 2025, by dialing 877-344-7529 (U.S.) or 412-317-0088 (International) and providing the passcode 8087517. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com

FAQ

When will OPKO Health (OPK) release Q4 2024 earnings?

OPKO Health will release its Q4 2024 earnings on February 27, 2025, after U.S. market close.

What time is OPKO Health's (OPK) Q4 2024 earnings call?

OPKO Health's Q4 2024 earnings conference call is scheduled for February 27, 2025, at 4:30 p.m. Eastern time.

How can investors access OPKO Health's (OPK) Q4 2024 earnings call?

Investors can pre-register through a provided link or dial 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast will also be available on OPKO's Investor Relations page.

How long will OPKO Health's (OPK) Q4 2024 earnings call replay be available?

The telephone replay will be available until March 6, 2025, and a webcast replay will be accessible approximately one hour after the live call.